Neurotechnology and Vision Review Branch – NV
Dr. Joseph Rudolph
Chief
Review Branch Summary
The Neurotechnology and Vision (NV) Review Branch is led by Dr. Joseph Rudolph. NV reviews crosscutting neuroscience and/or vision grant applications that focus on the development of novel technologies as well as the application of emerging technologies to neuroscience problems or on training in the neurosciences. The scientific areas are broad and include: genetics, bioengineering, drug development, bioinformatics, modeling, simulation, and imaging all in a neuroscience context. The NV Branch also reviews applications in the areas of vision technology, eye disorders and diseases including pathogenesis, diagnosis, detection, treatment, and prevention of eye disorders and disease. Areas covered in the areas of vision technology development include low vision technologies, low vision rehabilitation and assessment, imaging in the eye as well as retinal prosthetics and drug development.
Study Sections
- Bioengineering of Neuroscience, Vision Technologies*Ends after October 2024 council round meetings BNVT
- New! Bioengineering and Tissue Engineering for Neuroscience*Starts with January 2025 council round submission deadline BTEN
- Biophysical, Physiological, Pharmacological and Bioengineering Neuroscience, and Vision Fellowship Study Section F03B
- New! Imaging and Bioengineering Technology for Visual Systems*Starts with January 2025 council round submission deadline IBV
- New! Imaging Technology for Neuroscience*Starts with January 2025 council round submission deadline ITN
- New! Neuro Informatics, Computational and Data Analysis*Starts with January 2025 council round submission deadline NICD
- New! Neuromodulation and Imaging of Neuronal Circuits*Starts with January 2025 council round submission deadline NINC
- Clinical Neurophysiology, Devices, Neuroprosthetics and Biosensors Small Business SEP NV (10)
- Aging and Development, Auditory, Vision and Low Vision Technologies Small Business SEP NV (12)
- Neuroscience Assays, Diagnostics, Instrumentation and Interventions Small Business SEP NV (13)
- Drug Discovery for Aging, Neuropsychiatric and Neurologic Disorders Small Business SEP NV (14)
- Vision Imaging, Bioengineering, and Low Vision Technology Development (BIVT)*Ends after October 2024 council round meetings NV (81)
- Special Topics: Noninvasive Neuromodulation and Neuroimaging Technologies*Ends after October 2024 council round meetings NV (91)
- Pathophysiology of Eye Disease 1 PED1
- Pathophysiology of Eye Disease 2 PED2
